Systemic Treatments for Alopecia Areata Registry

Launched by ERASMUS MEDICAL CENTER · Feb 27, 2024

Keywords

ClinConnect Summary

The Systemic Treatments for Alopecia Areata Registry (STA2R) is a research study looking at how well different systemic treatments work for people with alopecia areata, which is a condition that causes hair loss. This study is being conducted at multiple locations and aims to gather information on the effectiveness, safety, and long-term effects of these treatments. The trial is currently recruiting participants, and anyone aged 5 to 43 who has been diagnosed with alopecia areata and is starting or currently using a systemic treatment may be eligible to join.

If you choose to participate, you'll be asked to give your consent and provide some information about your condition and treatment. The study will track your progress over time to see how you respond to the treatment. It's important to know that you need to be able to understand Dutch and be willing to participate in order to join the study. This registry aims to help improve future treatments for alopecia areata and support others dealing with this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with alopecia areata;
• • Starting/using a systemic treatment for alopecia areata;
• • Informed consent for registry participation obtained from patient and/or caretaker.
• Exclusion Criteria:
• • Not sufficiently capable of understanding the Dutch language;
• • Not willing to participate.